Gout diagnoses increased dramatically from 1990 to 2017, shows new analysis

The prevalence of gout--a form of arthritis characterized by severe pain, redness, and tenderness in joints--increased across the world at an alarming rate from 1990 to 2017, according to an analysis published in Arthritis & Rheumatology.

The analysis found that there were approximately 41.2 million prevalent cases of gout in 2017, with the rate of new diagnosed cases being 92 per 100,000 people, an increase of 5.5% from 1990.

Gout was more common in males and in older individuals. Also, the burden of gout was generally highest in developed regions and countries. High body mass index and impaired kidney function were risk factors for gout.

The increasing trend of gout burden is most likely to continue as the global aging population is on the rise. Attempts to lessen the disease onset and future burden of gout require better awareness, especially of risk factors, and early diagnosis and treatment."

Emma Smith, PhD, Study Senior Author, University of Sydney

Source:
Journal reference:

Safiri, S., et al. (2020) Prevalence, incidence and years lived with disability due to gout and its attributable risk factors for 195 countries and territories 1990‐2017: a systematic analysis of the Global Burden of Disease Study 2017. Arthritis & Rheumatology. doi.org/10.1002/art.41404.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Arthritis-style immunotherapy shows promise for heart failure